The International Federation of Red Cross and Red Crescent Societies (IFRC) is the world’s largest humanitarian network, with 191 member National Red Cross and Red Crescent Societies. IFRC uses the Triple R – response, resilience and respect – to deliver on Strategy 2030. IFRC responds to disasters and crises, ensuring timely, coordinated and locally led humanitarian action. IFRC supports its members in building community resilience in the areas of climate and environment, health and wellbeing, and migration and displacement. IFRC promotes respect for our fundamental principles of humanity, impartiality, neutrality, independence, voluntary service, unity, and universality, including in our work on values, power and inclusion. The IFRC focuses throughout on our core mandate – our raison d’être – of strategic and operational coordination, humanitarian diplomacy, National Society development, and accountability.
IFRC is led by its Secretary General and has its Headquarters in Geneva and five regional offices in Africa (Nairobi); the Americas (Panama); Asia Pacific (Kuala Lumpur); Europe (Budapest); and MENA (Beirut) as well as representation offices, service centres and delegations across the globe.
Due to the recent global financial cutbacks in public health and immunization activities, technical support to many country Ministries of Health in the African region has been withdrawn thereby seriously threatening the planning and implementation of vaccination campaigns in 2025 and 2026. As a consequence, a partnership between the IFRC and the Measles and Rubella Partnership (M&RP) seeks to establish a Measles & Rubella Country Platform (M&R Country Platform) to overcome this gap in technical support to the Ministries of Health. The M&R Country Platform serves to advance the goals of the Immunization Agenda 2030 and is committed to reducing measles and rubella morbidity and mortality by supporting countries to implement the Measles and Rubella Strategic Framework 2021- 2030.
Tajikistan is planning a follow-up measles–rubella supplementary immunization activity (MR SIA) in response to residual immunity gaps and the risk of further measles and rubella transmission. The campaign was planned for October 2026 in 54 cities and districts not covered by the 2025 outbreak-response campaign. It is intended to vaccinate children aged 6–59 months and achieve at least 95% coverage of the target group.
The Ministry of Health and Social Protection of the Population (MOHSPP), the Republican Centre for Immunoprophylaxis (RCIP), and partners intend to conduct a probability-based post-campaign coverage survey (PCCS) after completion of the campaign and any formally designated campaign mop-up period. The survey should be scheduled promptly enough to minimize recall error while allowing campaign records, the sampling frame, approvals and field arrangements to be finalized.
The PCCS will provide an independent population-based estimate of campaign vaccination coverage among eligible children in the targeted campaign area, quantify statistical uncertainty, describe who was missed and why, and inform corrective programme actions. Administrative coverage and other monitoring data may be triangulated with the PCCS, but their different denominators, purposes and limitations must be preserved.
This consultancy will provide end-to-end technical leadership and quality assurance for survey design, preparation, field implementation, data management, weighted analysis, reporting, dissemination, and transfer of all survey assets, while national bodies and partners retain decision-making and approval authority.
Project Objectives
Primary objective: Estimate MR SIA vaccination coverage among children who were aged 6–59 months on the approved campaign eligibility reference date and resided in the targeted campaign area, with design-adjusted 95% confidence intervals.
Secondary objective:
Scope boundary: This ToR is strictly limited to the post-campaign coverage survey. It excludes intra-campaign monitoring, rapid convenience monitoring, campaign-readiness assessment, LQAS/LQA design or classification, supervision of vaccination delivery, and implementation of mop-up vaccination.
1. Inception and governance
2. Protocol, approvals and probability sampling
3. Survey tools and data system
4. Recruitment, training, pilot and readiness
5. Field implementation and quality assurance
6. Data management and analysis
7. Reporting, dissemination and handover
Please find here for further details.
Location
The assignment is expected to be home-based with mission(s) to Dushanbe and selected survey areas in Tajikistan. The exact duty station, number of missions, travel dates and selected field areas will be confirmed after approval of the sample and field plan. Travel shall follow the IFRC’s authorization, security, medical clearance and insurance requirements. The consultant shall not commence travel without written authorization.
Support to be provided to the consultant
The consultant will be provided with support from the IFRC for travel, logistics, program management through the M&R Country Platform Office and Administrative Lead. Additional technical and administrative support may be provided through colleagues at the Regional Office.
Time allocation
The final start date, end date, workdays and mission schedule shall be agreed only after the survey design, national implementation arrangement, campaign calendar and fieldwork window are confirmed. The approved workplan shall allocate adequate time to inception; protocol and probability sampling; tools and data-system preparation; training and pilot; fieldwork quality assurance; data management and weighted analysis; and reporting, dissemination and handover. No field data collection may begin before required technical and administrative approvals are documented.
Any later reallocation of approved workdays requires prior written agreement; an increase in the approved total requires formal amendment.
Management of consultancy
The consultant will be directly managed by the IFRC M&R Country Platform Officer with overall coordination from the IFRC Immunization Senior Officer based in Geneva.
Required
Required
Preferred
Required
LANGUAGES
Required
Preferred
Application Instructions
Notes
The closing date and time for this vacancy are based on Geneva time. Applications must be submitted by 23:59 (11:59 PM) Geneva time on the advertised closing date.
We review listings for quality, but organizations may update or amend a posting at any time, so confirm the role and closing date on the organization’s official site before applying. No genuine employer charges a fee to apply, interview, or process an application — treat any request for payment as a scam. If a detail looks wrong or the posting seems fraudulent, report this job.